Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Schmidt

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Neuropsychologia|May 30, 2006
Can amnesic patients learn without awareness? New evidence comparing deterministic and probabilistic sequence learningMuriel Vandenberghe, Nicolas Schmidt, Patrick Fery, et al.
Bioresource Technology|March 18, 2011
Microbial fuel cell enables phosphate recovery from digested sewage sludge as struviteFabian Fischer, Christèle Bastian, Manuel Happe, et al.
European Neurology|June 13, 2009
Coping strategy and anxiety evolution in multiple sclerosis patients initiating interferon-beta treatmentThibault Moreau, Nicolas Schmidt, Olivier Joyeux, et al.
NPJ Digital Medicine|March 11, 2021
The emerging clinical role of wearables: factors for successful implementation in healthcareMatthew Smuck, Charles A Odonkor, Jonathan K Wilt, et al.
BMC Neurology|June 14, 2012
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot studyPatrick Vermersch, Rabah Benrabah, Nicolas Schmidt, et al.
Health Promotion Perspectives|November 1, 2017
Cross-Sectional and longitudinal associations of objectively-measured physical activity on blood pressure: evaluation in 37 countriesMehdi Menai, Benoit Brouard, Matthieu Vegreville, et al.
American Journal of Hypertension|January 25, 2018
Real World Home Blood Pressure Variability in Over 56,000 Individuals With Nearly 17 Million MeasurementsKwang-Il Kim, Nima Nikzad, Giorgio Quer, et al.
Alzheimer'S Research & Therapy|April 21, 2011
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trialFrançois Piette, Joël Belmin, Hélène Vincent, et al.
Plos One|August 3, 2023
Pregnant women with mild COVID-19 followed in community setting by telemedicine, and factors associated with unfavorable outcomeAurélien Dinh, Florian Drouet, Agnes Dechartres, et al.
Plos One|January 24, 2025
Correction: Pregnant women with mild COVID-19 followed in community setting by telemedicine, and factors associated with unfavorable outcomeAurélien Dinh, Florian Drouet, Agnes Dechartres, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Neuropsychologia|May 30, 2006
Can amnesic patients learn without awareness? New evidence comparing deterministic and probabilistic sequence learningMuriel Vandenberghe, Nicolas Schmidt, Patrick Fery, et al.
Bioresource Technology|March 18, 2011
Microbial fuel cell enables phosphate recovery from digested sewage sludge as struviteFabian Fischer, Christèle Bastian, Manuel Happe, et al.
European Neurology|June 13, 2009
Coping strategy and anxiety evolution in multiple sclerosis patients initiating interferon-beta treatmentThibault Moreau, Nicolas Schmidt, Olivier Joyeux, et al.
NPJ Digital Medicine|March 11, 2021
The emerging clinical role of wearables: factors for successful implementation in healthcareMatthew Smuck, Charles A Odonkor, Jonathan K Wilt, et al.
BMC Neurology|June 14, 2012
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot studyPatrick Vermersch, Rabah Benrabah, Nicolas Schmidt, et al.
Health Promotion Perspectives|November 1, 2017
Cross-Sectional and longitudinal associations of objectively-measured physical activity on blood pressure: evaluation in 37 countriesMehdi Menai, Benoit Brouard, Matthieu Vegreville, et al.
American Journal of Hypertension|January 25, 2018
Real World Home Blood Pressure Variability in Over 56,000 Individuals With Nearly 17 Million MeasurementsKwang-Il Kim, Nima Nikzad, Giorgio Quer, et al.
Alzheimer'S Research & Therapy|April 21, 2011
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trialFrançois Piette, Joël Belmin, Hélène Vincent, et al.
Plos One|August 3, 2023
Pregnant women with mild COVID-19 followed in community setting by telemedicine, and factors associated with unfavorable outcomeAurélien Dinh, Florian Drouet, Agnes Dechartres, et al.
Plos One|January 24, 2025
Correction: Pregnant women with mild COVID-19 followed in community setting by telemedicine, and factors associated with unfavorable outcomeAurélien Dinh, Florian Drouet, Agnes Dechartres, et al.
Pageof 2